I’m somewhat inclined to defer to putting ‘X is also known as Y’ in the Extra field/s for a few reasons. One, some alternate namings are super common, others less so, and routinely including them in the Text field lengthens the card considerably.
Not definitive on this, but it feels a bit more demure
@pkaps01 Testing testing, God are you there? It’s me, Margaret
agreed, we dont need to put every single alternative word in clozes although some already exist
I would suggest we change the text to the new name that I suggested then - adenylate cyclase and move adenylyl cyclase to the extra section. Kaplan, Khan Academy, and UWorld use adenylate cyclase not adenylyl cyclase. I’m not sure how this card ended up with adenylyl cyclase I just know from searching online it’s a less common term for adenylate cyclase.
I don’t really have strong feelings about this. Kaplan seems only to use ‘adenlate’ and UWorld uses both seemingly interchangeably. Both are widespread, common, and acceptable.
UWorld below:
My understanding, according to an eccentric labmate, is that ‘adenylate’ is for “old people” and is being phased out in favor of ‘adenylyl’ in more contemporary literature. Do with this info what you will. ¯_(ツ)_/¯
If we’re being really punctilious, the most reasonable option is probably to preserve the existing card as-is and put ‘adenylate’ in the Extra field if only bc the card has been ‘adenylyl’ since however long and there’s not a ton of reasoning behind disrupting existing card architecture for an interchangeable term, imo.
Thats fair. I honestly think this is one of the few places it makes sense to include both. Kaplan, AAMC Section Bank 1 Q82, and Khan Academy refer to it as adenylate cyclase.
Short synopsis of conversation here: the term we are using is not the one used by the AAMC.
adenyl cyclase is the proper term used nowadays so maybe should be added note in extra or just put in the same card like was suggested
Yeah, I think I stand about where I was before. We noted above that AAMC uses ‘adenylate’ though that was addressed previously.
Samesame
Sorry where are we in terms of where it should be included im confused. Change to just adenylate cyclase and move adenyly to the extra? or good as is in the suggestion?
Not as-is; don’t need both names in the text field, for sure.
In this case, bc both are commonplace and well-accepted, defer to existing card phrasing to avoid confusion/disruption for users, typical ‘X is also commonly known as Y’ in the Extra field
I thought the AAMC is kind of our bible though and we already think it’s a minority of users who take the time to really read the extra section. I mean only UWorld uses adenylyl cyclase. Khan Academy, Kaplan, most importantly AAMC use adenylate cyclase. Agree they dont both need to be in the text section but if one is wouldn’t it make sense to be the one that AAMC sides with as well as 2/3 primary resources. I agree it’s an interruption but wouldn’t it be best for us to test the term that we have the absolute best evidence users are likely to see on test day then risk a majority not reading the extra section and then being confused when they see adenylate. All good if you don’t think this is worth the interruption I’m just trying to learn/understand how to reason through these types of things and weigh sticking with the AAMC content against disruption.
I think most/all of the reasoning is as above, tbh.
Made adjustment
@AnKing-MCAT-Maintainers can we push this when one of you guys get a chance. Just had another AAMC question come up with it being adenylate.
lol sometimes i just assume someone else will do it. Diffusion of responsibility (bystander effect) if u will.